New Methods and Strategies for the Synthesis of ETP Natural Products
New Methods and Strategies for the Synthesis of ETP Natural Products
批准号:
8087471
负责人:
Sarah Elizabeth Reisman
金额:
$27.97万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2016-01-31
关键词:
Anti-Bacterial AgentsAntibioticsAntiviral AgentsBiologicalBiological FactorsBiologyCancer CenterCarbonChemistryCitiesCollaborationsCollectionCommunicable DiseasesComplexDNA-Directed RNA PolymeraseDevelopmentDiseaseExhibitsFamilyFoundationsFutureGliotoxinGlycolsGoalsIn VitroIndolesInstitutesKineticsMalignant neoplasm of prostateMethicillinMethodological StudiesMethodsOrganic ChemistryOrganometallic ChemistryPreparationPropertyReactionResearchStagingStaphylococcus aureusTherapeutic StudiesTinTransition Elementsanalogaranotincancer cellcancer therapychemical reactionchemical synthesiscycloadditioninhibitor/antagonistinnovationinsightmonomerquinolone resistancestereochemistryverticillin Aviral RNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Epidithiodiketopiperazine (ETP) natural products are a class of structurally complex fungal metabolites that exhibit biological properties including antiviral, antiproliferative, and antibacterial activities. The goal of the proposed research is to develop new synthetic methods and strategies for the synthesis of dihydrooxepine and pyrrolidinoindoline ETP natural products. The development of efficient chemical syntheses of ETP natural products is expected to facilitate the study of their biological properties, and demands innovative new methods to prepare dihydrooxepine and pyrrolidinoindoline core motifs. The proposed research comprises two projects, the first of which targets the natural products aranotin (2) and MPC1001B (5), and is expected to contribute new transition-metal catalyzed methods for the preparation of dihydrooxepines. In addition, the first comprehensive studies of ETP formation in the presence of a dihydrooxepine moiety will be carried out. The specific aims are: 1.1) to develop transition metal-catalyzed cycloisomerization reactions to prepare dihydrooxepines; 1.2) to complete a total synthesis of the antiviral natural project aranotin (2); 1.3) to complete a total synthesis of the antiproliferative natural product MPC1001B (5). The second project targets pyrrolidinoindoline ETPs such as 11-deoxybionectin A (8). To this end, a new enantioselective formal [3+2] cycloaddition to prepare pyrrolidinoindolines directly from indoles will be developed. The specific aims are: 2.1) to develop catalytic asymmetric formal [3+2] cycloaddition reactions to prepare pyrrolidinoindolines; 2.2) to study and elucidate the mechanism of catalytic asymmetric pyrrolidinoindoline formation; 2.3) to complete a total synthesis of 11-deoxybionectin A (8). Synthetic access to ETPs such as 2, 5, and 8, is expected to permit studies aimed at deepening our understanding of the underlying mechanisms of their biological properties. Through collaborations with the City of Hope Cancer Center and the Broad Institute of Harvard and MIT, these natural products and synthetic derivatives will be evaluated as biological probes and potential therapeutics for the study and treatment of cancer and infectious disease. It is anticipated that these studies will result in the development of new chemical reactions, further our fundamental understanding of organic and organometallic chemistry, and contribute valuable information on the chemistry and biology of two distinct families of ETP natural products.
PUBLIC HEALTH RELEVANCE: Epidithiodiketopiperazine (ETP) natural products are a structurally diverse group of fungal metabolites that exhibit an array of promising biological properties, including antibiotic, antiviral, and antiproliferative activities. This proposal aims to develop new chemical reactions and synthetic strategies for the chemical synthesis of ETP natural products. These studies will contribute valuable information about the chemistry and biology of ETP natural products, and in so doing, will facilitate the study and treatment of disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemical Synthesis of Chiral Bioactive Molecules
-
批准号:10645231
-
项目类别:
-
资助金额:$59.46万
-
财政年份:2016
-
负责人:Sarah Elizabeth Reisman
-
依托单位:
Chemical Synthesis of Chiral Bioactive Molecules
-
批准号:9071843
-
项目类别:
-
资助金额:$50.31万
-
财政年份:2016
-
负责人:Sarah Elizabeth Reisman
-
依托单位:
Chemical Synthesis of Chiral Bioactive Molecules
-
批准号:10389899
-
项目类别:
-
资助金额:$19.24万
-
财政年份:2016
-
负责人:Sarah Elizabeth Reisman
-
依托单位:
Chemical Synthesis of Chiral Bioactive Molecules
-
批准号:10184659
-
项目类别:
-
资助金额:$59.46万
-
财政年份:2016
-
负责人:Sarah Elizabeth Reisman
-
依托单位:
Chemical Synthesis of Chiral Bioactive Molecules
-
批准号:10400902
-
项目类别:
-
资助金额:$59.46万
-
财政年份:2016
-
负责人:Sarah Elizabeth Reisman
-
依托单位:
Catalytic Asymmetric Reductive Coupling Reactions to Prepare Bioactive Molecules
-
批准号:8887353
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2014
-
负责人:Sarah Elizabeth Reisman
-
依托单位:
Catalytic Asymmetric Reductive Coupling Reactions to Prepare Bioactive Molecules
-
批准号:8766494
-
项目类别:
-
资助金额:$29.3万
-
财政年份:2014
-
负责人:Sarah Elizabeth Reisman
-
依托单位:
New Methods and Strategies for the Synthesis of ETP Natural Products
-
批准号:8610929
-
项目类别:
-
资助金额:$29.14万
-
财政年份:2011
-
负责人:Sarah Elizabeth Reisman
-
依托单位:
New Methods and Strategies for the Synthesis of ETP Natural Products
-
批准号:8244426
-
项目类别:
-
资助金额:$28.83万
-
财政年份:2011
-
负责人:Sarah Elizabeth Reisman
-
依托单位:
New Methods and Strategies for the Synthesis of ETP Natural Products
-
批准号:8416968
-
项目类别:
-
资助金额:$28.18万
-
财政年份:2011
-
负责人:Sarah Elizabeth Reisman
-
依托单位:
Catalytic Asymmetric Synthesis of Piperidene Derivatives
-
批准号:7354809
-
项目类别:
-
资助金额:$1.69万
-
财政年份:2007
-
负责人:Sarah Elizabeth Reisman
-
依托单位:
海外基金